Yoga's effect on heart failure patients' quality of life
Randomized Pilot Trial: Impact of YOGA on the Quality of Life and Well-being of Heart Failure Patients
This study tests if yoga can improve the quality of life for people with chronic heart failure compared to those who participate in storytelling workshops.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 66 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT06019169 on ClinicalTrials.gov |
What this trial studies
This pilot study investigates the impact of yoga on the quality of life and well-being of patients with chronic heart failure. It involves a randomized controlled design with two groups: one participating in yoga classes and the other engaging in storytelling workshops. Patients will attend four sessions per month for three months, with the aim of assessing improvements in emotional and physical well-being. The study is conducted at the Pitié Salpêtrière cardiology institute, focusing on patients who are stabilized and have not practiced yoga recently.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with stabilized chronic heart failure and an LVEF of 50% or less.
Not a fit: Patients with severe renal impairment, certain heart conditions, or those who have practiced yoga regularly in the past six months may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life for heart failure patients through the incorporation of yoga into their treatment regimen.
How similar studies have performed: Previous studies have shown some benefits of yoga in heart failure, but this specific approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient ≥18 years old * Chronic heart failure patient defined by: Most recent LVEF ≤50% (regardless of measurement method) * Stabilized (last episode of acute heart failure dating back more than a month) in NYHA stage I to III dyspnoea, ambulatory, discharged from hospital for \> 1 month * Drug treatment optimized according to the judgment of the investigator * Ability to participate in activities as proposed (remote or face-to-face) * Patient affiliated with a social security scheme * Written consent to participate Exclusion Criteria: * Patients who have practiced yoga regularly (\> once a month) in the six months prior to selection. * Current pregnancy / lactation * Etiology of heart failure: hypertrophic cardiomyopathy, restrictive heart disease or severe curable valve disease * Severe renal impairment GFR\<25ml/min/1.73 m2 or on dialysis. * Persons subject to legal protection measures (guardianship, curatorship) * Person not "receptive" to the practice of yoga * Participation in intervention research
Where this trial is running
Paris
- Institut de Cardiologie, Centre Hospitalier Universitaire Pitié Salpêtrière (APHP), UPMC — Paris, France (Recruiting)
Study contacts
- Study coordinator: Lise LEGRAND, Dr
- Email: lise.legrand@aphp.fr
- Phone: 01 42 16 30 74
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.